Valvular Aortic valve

Structural heart disease

One-Year Mortality Trends Following TAVR: STS/ACC TVT Registry Outcomes

Transcatheter aortic valve replacement (TAVR) has quickly consolidated as a safe and effective treatment option for patients...

Dr. Andrés Rodríguez - 19 May, 2025

Learn More

Structural heart disease

Is Transcarotid Access a Safe Option in TAVI?

Transcatheter aortic valve implantation (TAVI) should preferably be conducted via transfemoral access, according to European guideline (in...

Dr. Carlos Fava - 14 May, 2025

Learn More

Pulmonary Valve

Endovascular Therapy for PE: Earlier Rather than Later Treatment, as in MI and Stroke?

Patients with pulmonary embolism (PE), whether intermediate-high or high risk, may progress to right ventricular (RV) dysfunction,...

Dr. Omar Tupayachi - 14 May, 2025

Learn More

Structural heart disease

5th Generation Balloon Expandable Valve in a Real World US Population: One-Year Outcomes

Transcatheter aortic valve replacement (TAVR) has consolidated as treatment for severe symptomatic aortic stenosis, even in low...

Dr. Andrés Rodríguez - 13 May, 2025

Learn More

Mitral valve

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

Atrial functional mitral regurgitation (aFMR), which results from atrial dilation without significant left ventricular dysfunction, accounts for...

Dr. Carlos Fava - 8 May, 2025

Learn More

Structural heart disease

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical...

Dr. Omar Tupayachi - 7 May, 2025

Learn More

Structural heart disease

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients...

Dr. Omar Tupayachi - 29 April, 2025

Learn More

Structural heart disease

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart...

Dr. Carlos Fava - 23 April, 2025

Learn More

One-Year Mortality Trends Following TAVR: STS/ACC TVT Registry Outcomes

Is Transcarotid Access a Safe Option in TAVI?

Endovascular Therapy for PE: Earlier Rather than Later Treatment, as in MI and Stroke?

5th Generation Balloon Expandable Valve in a Real World US Population: One-Year Outcomes

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access